A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-28
- Target Recruit Count
- 60
- Registration Number
- NCT00000864
- Locations
- ๐บ๐ธ
Univ. of Florida Jacksonville NICHD CRS, Jacksonville, Florida, United States
๐บ๐ธBronx-Lebanon Hosp. IMPAACT CRS, Bronx, New York, United States
๐ต๐ทSan Juan City Hosp. PR NICHD CRS, San Juan, Puerto Rico
Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-27
- Target Recruit Count
- 35
- Registration Number
- NCT00000630
- Locations
- ๐บ๐ธ
UW - Seattle AVEG, Seattle, Washington, United States
๐บ๐ธVanderbilt Univ. Hosp. AVEG, Nashville, Tennessee, United States
ALVAC-HIV vCP1452 Alone and Combined With MN rgp120
- Conditions
- HIV SeronegativityHIV Infections
- Interventions
- Biological: ALVAC(2)120(B,MN)GNP (vCP1452)Biological: ALVAC(2)120(B,MN)GNP (vCP1452) placeboBiological: MN rgp120/HIV-1 placeboBiological: MN rgp120/HIV-1
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-14
- Target Recruit Count
- 160
- Registration Number
- NCT00011037
- Locations
- ๐ต๐ช
Barranco CRS, Lima, Peru
๐ง๐ทProjeto Praรงa Onze/Hesfa Crs, Rio de Janeiro, Brazil
๐ญ๐นLes Centres GHESKIO CRS, Port-au-Prince, Haiti
A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
- Conditions
- HIV Infections
- Locations
- ๐บ๐ธ
Willow Clinic, Menlo Park, California, United States
๐บ๐ธStanford Univ Med Ctr, Stanford, California, United States
๐บ๐ธUniv of Colorado Health Sciences Ctr, Denver, Colorado, United States
Recombinant Human IL-4 Receptor Used in Treatment of Asthma
- Conditions
- Asthma
- Interventions
- Biological: Recombinant human soluble IL-4 receptorBiological: Placebo for Recombinant human soluble IL-4 receptor
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2016-03-07
- Target Recruit Count
- 62
- Registration Number
- NCT00017693
The Biology of HIV Transmission
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2015-10-22
- Target Recruit Count
- 20
- Registration Number
- NCT00001092
- Locations
- ๐บ๐ธ
Cedars Sinai Med Ctr, Los Angeles, California, United States
๐บ๐ธUCSD, San Diego, California, United States
๐บ๐ธSan Francisco Gen Hosp / UCSF AIDS Program, San Francisco, California, United States
Heterosexual HIV Transmission Study (HATS)
- Conditions
- HIV InfectionsHealthy
- Locations
- ๐บ๐ธ
UMDNJ - New Jersey Med School, Newark, New Jersey, United States
A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus
- Conditions
- HIV Infections
- Locations
- ๐บ๐ธ
Glaxo Wellcome Inc, Research Triangle Park, North Carolina, United States
A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia
- Conditions
- Pneumonia, Pneumocystis CariniiHIV Infections
- Locations
- ๐บ๐ธ
Warner-Lambert Parke-Davis, Morris Plains, New Jersey, United States
A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2012-05-21
- Target Recruit Count
- 200
- Registration Number
- NCT00000870
- Locations
- ๐บ๐ธ
The Ohio State Univ. AIDS CRS, Columbus, Ohio, United States
๐บ๐ธBeth Israel Deaconess - East Campus A0102 CRS, Boston, Massachusetts, United States
๐บ๐ธCase CRS, Cleveland, Ohio, United States